Impact BioMedical Inc. to Present at The Microcap Conference
Rhea-AI Summary
Impact BioMedical Inc. (NYSE American: IBO) has announced its participation in The Microcap Conference 2025, scheduled for January 28-30, 2025, at the Borgata Hotel Spa & Casino in Atlantic City, NJ. CEO Frank D. Heuszel will deliver a corporate presentation on Wednesday, January 29, 2025, at 10:30 AM ET.
During the conference, Heuszel will conduct one-on-one meetings with investors to discuss the company's recent developments, growth strategy, and investment opportunities. Impact BioMedical, a biotechnology company, focuses on discovering, confirming, and patenting unique science and technologies for development into biopharmaceuticals and consumer healthcare solutions through various collaborative relationships including research, licensing, co-development, and joint ventures.
Positive
- None.
Negative
- None.
News Market Reaction 1 Alert
On the day this news was published, IBO gained 12.68%, reflecting a significant positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
HOUSTON, Jan. 23, 2025 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a pioneering biotechnology company dedicated to discovering, developing, and patenting innovative healthcare solutions, today announced that Frank D. Heuszel, Chief Executive Officer, is pleased to announce his participation in The Microcap Conference 2025, the premier event for growth-focused companies and investors. The conference will take place January 28-30, 2025, at the Borgata Hotel Spa & Casino in Atlantic City, NJ.
Mr. Heuszel will deliver a corporate presentation and engage in one-on-one meetings with investors to discuss the company’s recent developments, growth strategy, and investment opportunities. Details regarding his presentation are below.
Impact BioMedical Inc. Microcap Conference Presentation
Date: Wednesday, January 29, 2025
Time: 10:30 AM ET
About Impact BioMedical, Inc.:
Impact BioMedical Inc. (NYSE American: IBO) discovers, confirms, and patents unique science and technologies which can be developed into new offerings in biopharmaceuticals and consumer healthcare and wellness in collaboration with external partners through research, licensing, co-development, joint ventures, and other relationships.
Investor Relations:
info@impactbiomedinc.com
FAQ
When is Impact BioMedical (IBO) presenting at The Microcap Conference 2025?
Where will The Microcap Conference 2025 featuring Impact BioMedical (IBO) be held?
What will be discussed during Impact BioMedical's (IBO) presentation at The Microcap Conference?
What is Impact BioMedical's (IBO) business focus according to their Microcap Conference announcement?
How can investors contact Impact BioMedical (IBO) for more information?
